LIGAND PHARMACEUTICALS INC (LGND)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Todd C. Davis Chief Executive Officer | 2025 | $724,500 | $0 | $5,520,493 | $4,441,120 | $764,400 | $21,582 | $11,472,095 |
| 2024 | $695,834 | $0 | $6,429,536 | $5,142,650 | $637,000 | $9,960 | $12,914,980 | |
| 2023 | $650,007 | $0 | $3,378,456 | $1,788,095 | $390,000 | $9,960 | $6,216,518 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Tavo Espinoza Chief Financial Officer | 2025 | $522,825 | $0 | $1,932,219 | $1,554,411 | $357,750 | $14,943 | $4,382,148 |
| 2024 | $469,550 | $0 | $1,428,806 | $1,142,820 | $250,000 | $7,380 | $3,298,556 | |
| 2023 | $433,005 | $0 | $1,201,271 | $635,773 | $173,202 | $7,380 | $2,450,631 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Andrew Reardon Chief Legal Officer and Secretary | 2025 | $476,675 | $0 | $1,656,171 | $1,332,345 | $268,800 | $13,291 | $3,747,282 |
| 2024 | $451,950 | $0 | $1,428,806 | $1,142,820 | $240,000 | $7,380 | $3,270,956 | |
| 2023 | $434,262 | $0 | $1,126,169 | $596,045 | $173,705 | $6,900 | $2,337,081 |